GO:0032377 regulation of intracellular lipid transport: Lipid Trafficking Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032377 (regulation of intracellular lipid transport) is a biological process that modulates the frequency, rate or extent of the directed movement of lipids within cells.
• Intracellular lipid transport encompasses the movement of cholesterol, phospholipids, sphingolipids and other lipids between organelles, and its dysregulation is linked to cardiovascular, metabolic and neurodegenerative diseases.
• Key regulatory nodes include ER-plasma membrane contact sites, lipid transfer proteins, and signaling pathways such as mTOR that reprogram lipid homeostasis.
• The perilipin homolog LSD2 regulates lipid-droplet transport, illustrating how motor-protein-dependent mechanisms control lipid distribution.
• Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis, linking this process to neurovascular function.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes controlling intracellular lipid transport.
Description
Regulation of intracellular lipid transport (GO:0032377) is defined as any process that modulates the frequency, rate or extent of the directed movement of lipids within cells. Lipids are not merely structural components; they serve as signaling molecules, energy stores, and membrane organizers, and their correct distribution among organelles is essential for cellular homeostasis. The directed movement of lipids within cells is a highly regulated process that ensures cholesterol, phospholipids, and sphingolipids reach their target membranes and metabolic compartments. This regulation is critical because imbalances in lipid transport contribute to pathologies ranging from atherosclerosis to neurodegeneration. At the mechanistic level, intracellular lipid transport is controlled by lipid transfer proteins, membrane contact sites, vesicular trafficking, and signaling cascades that sense lipid status. For example, the phosphatidylinositol cycle and phosphoinositide-driven lipid transport at ER-plasma membrane contact sites provide a hub for integrating lipid synthesis, transport, and signaling. Similarly, mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport, demonstrating that growth-signaling pathways directly regulate this process. For researchers, GO:0032377 provides a framework to study how cells coordinate lipid movement with metabolic demands, membrane remodeling, and stress responses. Understanding its regulation offers insights into disease mechanisms and identifies potential therapeutic targets, particularly in metabolic disorders and cancer.
regulation of intracellular lipid transport At A Glance
| GO ID | GO:0032377 |
|---|---|
| GO term | regulation of intracellular lipid transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of directed lipid movement within cells |
| Related processes | Intracellular cholesterol transport, phosphoinositide-driven lipid transport, lipid-droplet transport |
| Key regulators | Lipid transfer proteins, ER-PM contact sites, mTOR signaling, perilipin homolog LSD2 |
| Disease relevance | Cardiovascular disease, neurodegeneration, metabolic disorders, cancer |
What Is GO:0032377?
In our own words, GO:0032377 describes the regulatory processes that control how fast, how often, and to what extent lipids move in a directed manner inside cells. It does not describe the transport itself, but the modulation of that transport, including the proteins, signals, and membrane contact sites that govern lipid distribution among organelles.
Why Is regulation of intracellular lipid transport Important in Cell Biology?
Regulation of intracellular lipid transport is fundamental to cellular physiology because lipids must be delivered to specific organelles for membrane biogenesis, energy metabolism, and signaling. Disruption of this regulation leads to lipid accumulation, lipotoxicity, and organelle dysfunction, which are hallmarks of atherosclerosis, fatty liver disease, and neurodegeneration. Moreover, cancer cells often reprogram lipid transport to support rapid proliferation and survival. Therefore, understanding GO:0032377 is essential for identifying therapeutic targets and biomarkers across a spectrum of human diseases.
• Maintains membrane lipid asymmetry and organelle identity.
• Supports energy homeostasis by directing fatty acids to mitochondria or lipid droplets.
• Regulates blood-brain barrier permeability via caveolae-mediated transcytosis.
• Integrates with growth signaling pathways such as mTOR to match lipid supply with demand.
• Controls cholesterol trafficking, influencing atherosclerosis and foam cell formation.
• Modulates phosphoinositide signaling at ER-plasma membrane contact sites.
• Impacts mitochondrial choline import and metabolism through SLC25A48.
• Dysregulation contributes to neurodegeneration and neuroinflammation.
• Provides targets for CRISPR-based functional genomics in metabolic diseases.
• Enables synthetic biology approaches to engineer lipid-producing cells.
What Happens During regulation of intracellular lipid transport?
Initiation at membrane contact sites
In simple terms: Lipid transport often starts where two organelles touch, allowing lipids to hop between them.
ER-plasma membrane contact sites serve as platforms for phosphoinositide-driven lipid transport, where the phosphatidylinositol cycle integrates lipid synthesis and transfer. These sites are regulated by lipid transfer proteins that extract lipids from one membrane and deliver them to another, a process modulated by calcium and phosphoinositide signals.
Vesicular and non-vesicular transport
In simple terms: Lipids can move in bubbles (vesicles) or via carrier proteins.
Intracellular cholesterol transport involves both vesicular and non-vesicular mechanisms, with proteins such as NPC1 and NPC2 regulating endosomal cholesterol egress. Non-vesicular transport is mediated by lipid transfer proteins at contact sites, which are regulated by phosphorylation and lipid environment.
Cytoskeletal and motor-dependent movement
In simple terms: Some lipid droplets are pulled along tracks by motor proteins.
The perilipin homolog LSD2 regulates lipid-droplet transport by recruiting motors, linking lipid storage organelles to the cytoskeleton. This regulation ensures proper distribution of lipid droplets during development and metabolic transitions.
Signaling control by mTOR and nutrient sensors
In simple terms: Cells sense nutrients and adjust lipid movement accordingly.
mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport, demonstrating that growth signaling directly modulates GO:0032377. This ensures lipid availability matches biosynthetic demands.
Mitochondrial lipid import and metabolism
In simple terms: Mitochondria need specific lipids, and their import is regulated.
SLC25A48 controls mitochondrial choline import and metabolism, a process that impacts lipid transport into mitochondria and downstream phospholipid synthesis. This regulation is critical for mitochondrial membrane integrity and function.
Key Genes Involved in GO:0032377 regulation of intracellular lipid transport
The following genes and proteins are experimentally implicated in the regulation of intracellular lipid transport (GO:0032377).
| Gene | Major Role | Research Relevance |
|---|---|---|
| LSD2 | Regulates lipid-droplet transport via motor recruitment | Model for studying lipid droplet dynamics in development |
| mTOR | Signaling hub that reprograms lipid homeostasis and cholesterol transport | Target for cancer and metabolic disease research |
| SLC25A48 | Controls mitochondrial choline import and metabolism | Links lipid transport to mitochondrial function |
| NPC1 | Regulates endosomal cholesterol egress | Mutations cause Niemann-Pick type C disease |
| NPC2 | Binds cholesterol in lysosomes for transfer | Defects lead to cholesterol trafficking disorders |
| Caveolin-1 | Suppresses caveolae-mediated transcytosis at BBB | Regulates blood-brain barrier permeability |
| PI4K | Synthesizes phosphoinositides at ER-PM contact sites | Controls lipid transport and signaling |
| PITP | Transfers phosphatidylinositol between membranes | Essential for phosphoinositide-driven transport |
| OSBP | Transfers cholesterol and phosphatidylinositol-4-phosphate | Regulates ER-Golgi lipid exchange |
| CERT | Transfers ceramide from ER to Golgi | Sphingolipid homeostasis |
| ABCA1 | Mediates cholesterol efflux to apoA-I | Target in atherosclerosis research |
| SR-BI | Facilitates selective cholesterol uptake | Lipoprotein metabolism |
| ACAT | Converts cholesterol to cholesteryl esters for storage | Lipid droplet formation |
| PLIN2 | Coats lipid droplets and regulates lipolysis | Lipid storage and mobilization |
| Rab proteins | Regulate vesicular transport of lipids | Membrane trafficking |
| SNARE proteins | Mediate membrane fusion in lipid transport | Vesicle docking |
| VPS34 | Produces PI3P for endosomal lipid sorting | Autophagy and endosomal transport |
How Is regulation of intracellular lipid transport Regulated?
Regulation of intracellular lipid transport is controlled by multiple signaling pathways. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport, indicating that mTOR integrates nutrient status with lipid trafficking. The phosphatidylinositol cycle at ER-plasma membrane contact sites provides a regulatory hub where phosphoinositides and calcium signals modulate lipid transfer protein activity. Additionally, the perilipin homolog LSD2 regulates lipid-droplet transport in response to developmental and metabolic cues. These layers of regulation ensure that lipid distribution adapts to cellular demands.
regulation of intracellular lipid transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C disease | Knockout iPSC-derived neurons |
| Caveolin-1 | Blood-brain barrier dysfunction | Endothelial cell knockout |
| mTOR | Cancer and metabolic disorders | Kinase-dead knock-in |
| SLC25A48 | Mitochondrial choline metabolism defects | Overexpression in hepatocytes |
| LSD2 | Lipid droplet transport disorders | Point mutation in Drosophila |
Neurodegeneration and blood-brain barrier dysfunction
Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis, and its disruption is linked to neurovascular dysfunction. Impaired intracellular lipid transport can lead to lipid accumulation in neurons, contributing to neurodegeneration.
Cardiovascular disease and atherosclerosis
Intracellular cholesterol transport is a key determinant of foam cell formation and atherosclerosis. Defects in cholesterol trafficking proteins such as NPC1 and ABCA1 lead to lipid accumulation in macrophages and vascular cells.
Metabolic disorders and cancer
mTOR inhibition reprograms lipid homeostasis, and dysregulated lipid transport supports cancer cell proliferation and survival. Targeting lipid transport pathways is a promising therapeutic strategy in metabolic diseases and cancer.
From regulation of intracellular lipid transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate cholesterol transport? | Knockout cell line |
| Does a point mutation in gene Y alter lipid droplet motility? | Point mutation knock-in |
| Can overexpression of gene Z enhance lipid transport? | Overexpression stable pool |
| Where does protein X localize during lipid transport? | Tagged knock-in (e.g., GFP) |
| Which genes are essential for ER-PM lipid transfer? | CRISPR library screening |
| Does mTOR inhibition reprogram lipid uptake? | Pharmacological + knockout |
How to Study the regulation of intracellular lipid transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BODIPY-cholesterol imaging | Cholesterol trafficking | Live-cell transport assays |
| Lipidomics (LC-MS) | Lipid species abundance | Metabolic profiling |
| CRISPR knockout screen | Gene essentiality for lipid transport | Discovery of regulators |
| Proximity ligation assay | Protein-protein interactions at contact sites | ER-PM contact site mapping |
| In vitro lipid transfer assay | Transfer rate between liposomes | Reconstitution of transport |
| Live imaging of lipid droplets | Droplet motility | Motor-dependent transport |
| Phosphoinositide pulldown | PI species at membranes | Signaling lipid analysis |
Fluorescence imaging of lipid probes
Live-cell imaging with fluorescent lipid analogs (e.g., BODIPY-cholesterol) allows tracking of intracellular lipid transport in real time. This method visualizes lipid droplet dynamics and membrane contact sites.
Proteomics and lipidomics
Mass spectrometry-based lipidomics quantifies lipid species and reveals changes in transport pathways. Proteomics identifies protein complexes at membrane contact sites.
Genetic screens and CRISPR libraries
CRISPR knockout libraries enable unbiased discovery of genes regulating lipid transport. Pooled screens with lipid-sensitive reporters identify novel regulators.
Biochemical transport assays
In vitro assays with isolated organelles measure lipid transfer between membranes. These assays define the kinetics and specificity of lipid transfer proteins.
How CRISPR Can Be Used to Study GO:0032377 regulation of intracellular lipid transport
Knockout
CRISPR knockout of candidate genes (e.g., NPC1, LSD2) abolishes protein function and reveals their role in intracellular lipid transport. Knockout cell lines are used to measure lipid accumulation and trafficking defects.
Point Mutation
Point mutations introduced by CRISPR base editing or HDR mimic disease-associated variants in lipid transport genes, allowing functional assessment of specific residues. This approach is valuable for studying LSD2 motor recruitment domains.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci enables real-time visualization of lipid transport proteins at native expression levels. Tagged knock-in models are used to track protein dynamics at contact sites.
Overexpression
CRISPR activation or cDNA overexpression increases gene dosage to test sufficiency in promoting lipid transport. Overexpression of mTOR targets can reprogram lipid homeostasis.
How EDITGENE Supports regulation of intracellular lipid transport Research
Researchers studying regulation of intracellular lipid transport-related genes often need to determine whether a candidate gene is causally involved in lipid trafficking, and CRISPR-based models provide the most direct approach. EDITGENE offers a comprehensive suite of services to generate and characterize such models.
Contact EDITGENE today to design your custom CRISPR model for regulation of intracellular lipid transport research.
Frequently Asked Questions About regulation of intracellular lipid transport
What is GO:0032377?
GO:0032377 is the Gene Ontology term for regulation of intracellular lipid transport, defined as any process that modulates the frequency, rate or extent of the directed movement of lipids within cells.
What genes are involved in regulation of intracellular lipid transport?
Key genes include NPC1, NPC2, LSD2, mTOR, SLC25A48, and caveolin-1, among others.
How is intracellular lipid transport regulated?
It is regulated by lipid transfer proteins, membrane contact sites, phosphoinositide signaling, and nutrient sensors such as mTOR.
What diseases are linked to defective intracellular lipid transport?
Diseases include Niemann-Pick type C, atherosclerosis, neurodegeneration, and cancer.
What methods study intracellular lipid transport?
Methods include live-cell imaging with BODIPY-cholesterol, lipidomics, CRISPR screens, and in vitro transport assays.
Can CRISPR be used to study lipid transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in lipid transport.
What is the role of mTOR in lipid transport?
mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport.
How does LSD2 regulate lipid droplets?
LSD2, a perilipin homolog, regulates lipid-droplet transport by recruiting motor proteins.
What is the connection between lipid transport and the blood-brain barrier?
Lipid transport-dependent suppression of caveolae-mediated transcytosis regulates blood-brain barrier permeability.
What is SLC25A48?
SLC25A48 controls mitochondrial choline import and metabolism, impacting lipid transport into mitochondria.
Conclusion
Regulation of intracellular lipid transport (GO:0032377) is a central biological process that ensures lipids are correctly distributed within cells. Its dysregulation underlies major human diseases, and ongoing research continues to uncover new regulatory mechanisms. CRISPR-based models are indispensable for causal dissection of this process, and EDITGENE provides end-to-end solutions to accelerate discovery.
References
- 1. Andreone BJ et al.. 2017. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis.. Neuron 94(3):581-594.e5 PMID: 28416077
- 2. Pemberton JG et al.. 2020. Integrated regulation of the phosphatidylinositol cycle and phosphoinositide-driven lipid transport at ER-PM contact sites.. Traffic 21(2):200-219 PMID: 31650663
- 3. Verkerke ARP et al.. 2024. SLC25A48 controls mitochondrial choline import and metabolism.. Cell Metab 36(9):2156-2166.e9 PMID: 39111307
- 4. Soccio RE et al.. 2004. Intracellular cholesterol transport.. Arterioscler Thromb Vasc Biol 24(7):1150-60 PMID: 15130918
- 5. Fielding CJ et al.. 1997. Intracellular cholesterol transport.. J Lipid Res 38(8):1503-21 PMID: 9300773
- 6. Shin S et al.. 2025. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport.. Mol Cell 85(18):3486-3504.e7 PMID: 40972529
- 8. Welte MA et al.. 2005. Regulation of lipid-droplet transport by the perilipin homolog LSD2.. Curr Biol 15(14):1266-75 PMID: 16051169
